ArticleSocial psychiatry and psychiatric epidemiology2026
Longitudinal trends and causal relationships of depression, anxiety, and sleep quality among MSM newly diagnosed with HIV.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to characterize the longitudinal trajectories of depression, anxiety, and poor sleep among MSM newly diagnosed with HIV, and secondarily to explore potential causal relationships of HIV infection on these mental health outcomes.
methodsA prospective repeated-measures study was conducted between 2017 and 2020 at Beijing Youan Hospital. Newly diagnosed MSM patients with HIV were consecutively enrolled. Depressive and anxiety symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS), while sleep quality was evaluated with the Pittsburgh Sleep Quality Index (PSQI). Follow-up assessments were performed at 4, 12, and 24 weeks to track longitudinal changes in mental health status. As a complementary approach, Mendelian randomization (MR) analysis was employed to explore potential causal relationships of HIV infection on depression, anxiety, and sleep disturbances.
resultsA total of 1,170 MSM newly diagnosed with HIV were enrolled. The prevalence of depression, anxiety, and poor sleep decreased from 26.82%, 33.90%, and 65.91% at baseline to 12.75%, 15.47%, and 46.28% at week 24, respectively. Longitudinal analysis revealed that the prevalence of poor sleep among MSM newly diagnosed with HIV remained above 45% throughout the follow-up period, consistently exceeding the peak prevalence of depression or anxiety by over 20%. While depression and anxiety declined rapidly by week 4 and remained predominantly mild, a modest rebound occurred for moderate-to-severe cases at week 24 and for poor sleep at week 12. Notably, individuals with normal baseline sleep also exhibited a slight rebound increase in PSQI scores at week 12. MR analysis found no potentially causal association between HIV infection and depression (IVW: OR = 1.001, P = 0.208), anxiety (OR = 1.001, P = 0.051), and sleep disorders (OR = 1.002, P = 0.893), respectively.
conclusionsAlthough the overall prevalence of mental problems showed a declining trend, poor sleep demonstrated persistence and a rebound pattern. Proactive screening and mental support during the initial post-diagnosis period are essential to address modifiable risk factors and improve long term outcomes.
Indexed as
Identifiers
42234126What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.